Abstract

Inflammatory Bowel Diseases (IBD) (Inflammatory Bowel Diseases and the Microbiome: Searching the Crime Scene for Clues)

Gastroenterology. 2020 Nov 27;S0016-5085(20)35507-4. doi: 10.1053/j.gastro.2020.09.056.Online ahead of print.

Mirae Lee 1, Eugene B Chang 2

 
     

Author information

  • 1Committee on Microbiology, University of Chicago, Chicago, IL 60637; Department of Medicine, University of Chicago, Chicago, IL 60637.
  • 2Committee on Microbiology, University of Chicago, Chicago, IL 60637; Department of Medicine, University of Chicago, Chicago, IL 60637. Electronic address: echang@medicine.bsd.uchicago.edu.

Abstract

Inflammatory bowel diseases (IBD) develop via convergence of environmental, microbial, immunological, and genetic factors. Alterations in the gut microbiota have been associated with development and progression of IBD, but it is not clear which populations of microbes are involved or how they might contribute to IBD. We review the genetic and environmental factors affecting the gut microbiota, the roles of gut microbes and their bioproducts in the development and clinical course of IBD, and strategies by which microbiome-based therapies can be used to prevent, manage, and eventually cure IBD. We discuss research findings that help bridge the gap between the basic sciences and clinical application.

© Copyright 2013-2021 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.